PNP chief lauds Cordillera's fight vs illegal drugs | SunStar

PNP chief lauds Cordillera's fight vs illegal drugs

Time to read
less than
1 minute
Read so far

PNP chief lauds Cordillera's fight vs illegal drugs

Friday, October 06, 2017

PHILIPPINE National Police (PNP) Director General Ronald dela Rosa lauded the Cordillera's fight against illegal drugs.

"They [the region] are performing very well by clearing three provinces as compared to other regions in the country wherein they are still in the process of clearing in the Barangay level,” as the chief PNP rated the Cordillera’s performance on the war on drugs to be very good.

Dela Rosa stood as guest during the 116th Police Service Anniversary of the Police Regional Office on Friday, October 6, where the Philippine Drug Enforcement Agency and Police Regional Office Cordillera declared the provinces of Apayao, Ifugao, and Mt. Province as drug free.

"Having to clear three provinces in the region is good enough, there is still a need to intensify our war on drugs to ensure that we will finally rid the barangays of this menace", the General said.

Based on the PNP's monitoring, 74 percent of the barangays in the country are affected by the drug trade.

In reaction to the latest Social Weather Station or SWS survey indicating 9 out of 10 persons favor drug personalities caught to be alive rather than dead, Dela Rosa clarified "It is not the policy of the PNP to kill drug personalities, but we would have to defend ourselves when confronted with these personalities.”

Dela Rosa said "As much as possible, your PNP favors subduing drug personalities alive rather than dead, but it is very unfortunate if they would be killed in the process of arresting by our operatives since they would have to defend themselves in the process.”

Published in the SunStar Baguio newspaper on October 07, 2017.

Latest issues of SunStar Baguio also available on your mobile phones, laptops, and tablets. Subscribe to our digital editions at epaper.sunstar.com.ph and get a free seven-day trial.


View Comments